# Biograft Transplant Services Inc, Houston, TX – FDA Inspections

Source: https://www.keypedia.com/companies/biograft-transplant-services-inc/fab992db-4029-46e2-bc21-acb4fe75c65c

> Inspection records and compliance data for Biograft Transplant Services Inc in Houston, Texas. 4 FDA inspections on record, 1 Form 483, last inspected February 26, 2026.

---

## Details

- Name: Biograft Transplant Services Inc
- FEI Number: 3001238010
- Address Line 1: 11205 Main St Ste 114
- City: Houston
- State: Texas
- Zip Code: 77025
- Country Name: United States
- Address: 11205 Main St Ste 114, Houston, Texas 77025, United States
- Country: United States

## Related Documents

- [483 - Biograft Transplant Services Inc - 2026-02-26](https://www.keypedia.com/records/483/biograft-transplant-services-inc/28e00fda-8f43-4a71-8219-5481df157ade) — source: FDA, date: February 26, 2026
- [FDA Inspection 1307000 - Biograft Transplant Services Inc - 2026-02-26](https://www.keypedia.com/records/fda_inspections/biograft-transplant-services-inc/78b62334-0d38-4eb1-b391-d109f942a6bb) — source: FDA, date: February 26, 2026
- [483 - Biograft Transplant Services Inc - 2021-08-27](https://www.keypedia.com/records/483/biograft-transplant-services-inc/7c9a3595-838a-4b86-bc7c-27aea562d822) — source: FDA, date: August 27, 2021
- FDA Inspection 1149912 - Biograft Transplant Services Inc - 2021-08-27 — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 27, 2021
- FDA Inspection 1149912 - Biograft Transplant Services Inc - 2021-08-27 — classification: No Action Indicated (NAI), source: FDA, date: August 27, 2021
- FDA Inspection 1149912 - Biograft Transplant Services Inc - 2021-08-27 — classification: No Action Indicated (NAI), source: FDA, date: August 27, 2021
- FDA Inspection 1043589 - Biograft Transplant Services Inc - 2018-02-22 — classification: No Action Indicated (NAI), source: FDA, date: February 22, 2018
- FDA Inspection 1043589 - Biograft Transplant Services Inc - 2018-02-22 — classification: No Action Indicated (NAI), source: FDA, date: February 22, 2018
- FDA Inspection 983242 - Biograft Transplant Services Inc - 2016-06-07 — classification: No Action Indicated (NAI), source: FDA, date: June 7, 2016

## Related Companies

- [Texoma Regional Blood Center](https://www.keypedia.com/companies/texoma-regional-blood-center/cc65fa03-5945-4ee8-b9fb-5fb690840c98)
- [CellRight Technologies LLC](https://www.keypedia.com/companies/cellright-technologies-llc/94f7bd83-92c4-4c6c-b79d-0540ad99f903)
- [Fertility Specialists of Texas PLLC.](https://www.keypedia.com/companies/fertility-specialists-of-texas-pllc/a38a7d91-420d-41bb-875f-956bdfc5f16b)
- [New York Blood Center Enterprises](https://www.keypedia.com/companies/new-york-blood-center-enterprises/9a6a3572-57ad-4dc4-977f-d38116628d8c)
- [Skye Biologics Holdings LLC](https://www.keypedia.com/companies/skye-biologics-holdings-llc/955a9fe7-05a2-4d51-b376-f37b83dd7928)
- [Lexington Medical Center](https://www.keypedia.com/companies/lexington-medical-center/9dc08ec7-0424-445a-9b58-63c094fd3012)
- [Eversight Illinois](https://www.keypedia.com/companies/eversight-illinois/7b7a3e81-0ca7-4d57-b230-5dc8e929c6a6)
- [Nemours Alfred I. duPont Hospital for Children](https://www.keypedia.com/companies/nemours-alfred-i-dupont-hospital-for-children/fefd4e17-c707-48c1-9d64-984f34ee8fb1)
- [Montefiore Medical Center Blood Bank](https://www.keypedia.com/companies/montefiore-medical-center-blood-bank/7033c869-0208-41d0-9a7a-2ea327dba84a)
- [Generation Next Fertility](https://www.keypedia.com/companies/generation-next-fertility/541bb461-41e8-4d7b-be1d-e73204a802a8)

## Related Officers

- [issuing_officer](https://www.keypedia.com/people/jennifer-a-kemp/51aa8f2f-ba64-47d3-aa06-b4595b3d15c8)
- [Investigator](https://www.keypedia.com/people/darla-j-christopher/64d3f47f-f3c0-4cfd-a3e8-4dc0e69d04bd)
- [investigator](https://www.keypedia.com/people/mizanne-e-lewis/c79964ac-5163-44a2-89e9-8cc8775de9b4)
